Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
New Troponin Test Improves Heart Attack Diagnostics
11/01/2022
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency.
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency.
A new test has been developed in...
11/01/2022
Cath Lab Digest
News
Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions
11/01/2022
New research shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
New research shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.
New research shows the use of...
11/01/2022
Cath Lab Digest
News
First MitraClip Procedure Guided by 4D Hologram Software Performed at UC Davis Health
11/01/2022
The first MitraClip procedure using EchoPixel’s Holographic Therapy Guidance (HTG) was performed by Structural Heart Physicians at UC Davis Health.
The first MitraClip procedure using EchoPixel’s Holographic Therapy Guidance (HTG) was performed by Structural Heart Physicians at UC Davis Health.
The first MitraClip procedure...
11/01/2022
Cath Lab Digest
News
First-Ever Late-Breaking Clinical Trial Results Announced at The VEINS 2022
11/01/2022
The VEINS (Venous Endovascular INterventional Strategies) is an annual venous education symposium that brings together a global, multispecialty faculty to present a comprehensive variety of talks and case presentations focused on venous care.
The VEINS (Venous Endovascular INterventional Strategies) is an annual venous education symposium that brings together a global, multispecialty faculty to present a comprehensive variety of talks and case presentations focused on venous care.
The VEINS (Venous Endovascular...
11/01/2022
Cath Lab Digest
News
Johnson & Johnson to Acquire Abiomed
11/01/2022
New Brunswick, N.J. and Danvers, Mass., November 1, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung...
New Brunswick, N.J. and Danvers, Mass., November 1, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung...
New Brunswick, N.J. and Danvers,...
11/01/2022
Cath Lab Digest
News
SIRONA Completes Enrollment! A Leap in the DCB Treatment of Femoropopliteal Arterial Disease 
11/01/2022
Sirolimus DCB treatment is well established as safe and effective option in both coronary and peripheral artery disease segment.
Sirolimus DCB treatment is well established as safe and effective option in both coronary and peripheral artery disease segment.
Sirolimus DCB treatment is well...
11/01/2022
Cath Lab Digest
News
First Patient Enrolled in Reflow Medical’s DEEPER REVEAL IDE Clinical Study
11/01/2022
The DEEPER REVEAL trial is a prospective, single-arm, multicenter study that will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in patients with critical limb ischemia (CLI).
The DEEPER REVEAL trial is a prospective, single-arm, multicenter study that will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in patients with critical limb ischemia (CLI).
The DEEPER REVEAL trial is a...
11/01/2022
Cath Lab Digest
News
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
10/31/2022
Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe and effective to treat acute right heart failure for up to...
Abiomed announced that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe and effective to treat acute right heart failure for up to...
Abiomed announced that Impella...
10/31/2022
Cath Lab Digest
News
Gore Completes First in-Human Implants of the Gore Viafort Vascular Stent
10/31/2022
FLAGSTAFF, Ariz. — W. L. Gore & Associates (Gore) announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently initiated GORE VIAFORT Device Pivotal Clinical Study, (i.e.,...
FLAGSTAFF, Ariz. — W. L. Gore & Associates (Gore) announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently initiated GORE VIAFORT Device Pivotal Clinical Study, (i.e.,...
FLAGSTAFF, Ariz. — W. L....
10/31/2022
Cath Lab Digest
News
ESC: Short Bursts of Vigorous Activity Linked with Increased Longevity
10/31/2022
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology
Two minute bursts of vigorous activity totalling 15 minutes a week are associated with a reduced risk of death, according to research published today in European Heart Journal, a journal of the European Society of Cardiology
Two minute bursts of vigorous...
10/31/2022
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement